Your browser doesn't support javascript.
loading
Ubiquitinome Profiling Reveals in Vivo UBE2D3 Targets and Implicates UBE2D3 in Protein Quality Control.
Yalçin, Zeliha; Koot, Daniëlle; Bezstarosti, Karel; Salas-Lloret, Daniel; Bleijerveld, Onno B; Boersma, Vera; Falcone, Mattia; González-Prieto, Román; Altelaar, Maarten; Demmers, Jeroen A A; Jacobs, Jacqueline J L.
Afiliação
  • Yalçin Z; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Koot D; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bezstarosti K; Proteomics Center, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Salas-Lloret D; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Bleijerveld OB; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Boersma V; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Falcone M; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • González-Prieto R; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands; Genome Proteomics Laboratory, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Seville, Seville, Spain; Department of Cell Biology, University of Seville, Sev
  • Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Netherlands Proteomics Center, University of Utrecht, Utrecht, The Netherlands
  • Demmers JAA; Proteomics Center, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Jacobs JJL; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: j.jacobs@nki.nl.
Mol Cell Proteomics ; 22(6): 100548, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37059365
Ubiquitination has crucial roles in many cellular processes, and dysregulation of ubiquitin machinery enzymes can result in various forms of pathogenesis. Cells only have a limited set of ubiquitin-conjugating (E2) enzymes to support the ubiquitination of many cellular targets. As individual E2 enzymes have many different substrates and interactions between E2 enzymes and their substrates can be transient, it is challenging to define all in vivo substrates of an individual E2 and the cellular processes it affects. Particularly challenging in this respect is UBE2D3, an E2 enzyme with promiscuous activity in vitro but less defined roles in vivo. Here, we set out to identify in vivo targets of UBE2D3 by using stable isotope labeling by amino acids in cell culture-based and label-free quantitative ubiquitin diGly proteomics to study global proteome and ubiquitinome changes associated with UBE2D3 depletion. UBE2D3 depletion changed the global proteome, with the levels of proteins from metabolic pathways, in particular retinol metabolism, being the most affected. However, the impact of UBE2D3 depletion on the ubiquitinome was much more prominent. Interestingly, molecular pathways related to mRNA translation were the most affected. Indeed, we find that ubiquitination of the ribosomal proteins RPS10 and RPS20, critical for ribosome-associated protein quality control, is dependent on UBE2D3. We show by Targets of Ubiquitin Ligases Identified by Proteomics 2 methodology that RPS10 and RPS20 are direct targets of UBE2D3 and demonstrate that the catalytic activity of UBE2D3 is required to ubiquitinate RPS10 in vivo. In addition, our data suggest that UBE2D3 acts at multiple levels in autophagic protein quality control. Collectively, our findings show that depletion of an E2 enzyme in combination with quantitative diGly-based ubiquitinome profiling is a powerful tool to identify new in vivo E2 substrates, as we have done here for UBE2D3. Our work provides an important resource for further studies on the in vivo functions of UBE2D3.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteoma / Ubiquitina Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Cell Proteomics Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteoma / Ubiquitina Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Cell Proteomics Assunto da revista: BIOLOGIA MOLECULAR / BIOQUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos